Trends in AIDS-Defining Opportunistic Illnesses Incidence over 25 Years in Rio de Janeiro, Brazil-Reference-Cited by-同舟云学术

Trends in AIDS-Defining Opportunistic Illnesses Incidence over 25 Years in Rio de Janeiro, Brazil

Published:2014-06-05 Issue:6 Volume:9 Page:e98666
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Coelho Lara,Cardoso Sandra Wagner,Amancio Rodrigo Teixeira,Moreira Ronaldo Ismério,Campos Dayse Pereira,Veloso Valdiléa Gonçalves,Grinsztejn Beatriz,Luz Paula Mendes

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Treatment of latent tuberculosis infection in HIV infected persons;C Akolo;Cochrane Database Syst,2010

2. The spectrum and prognosis of AIDS-defining illnesses in Cape Town;M Badri;The Southern African Journal of HIV Medicine,2005

3. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study;M Badri;Lancet,2002

4. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy;HR Brodt;Aids,1997

5. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005;K Buchacz;Aids,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in the epidemiology and clinical manifestations of human immunodeficiency virus–associated tuberculosis in Hong Kong;Hong Kong Medical Journal;2024-07-16

2. Features and global impact of invasive fungal infections caused by Pneumocystis jirovecii: A systematic review to inform the World Health Organization fungal priority pathogens list;Medical Mycology;2024-06

3. High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency department;Medical Mycology;2023-09-01

4. Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil;AIDS Research and Therapy;2023-08-21

5. Pharmacokinetics of Efavirenz 600mg in Combination with Rifampicin in Chinese HIV/TB Co-Infection Patients;Infection and Drug Resistance;2023-07